Meadow Creek Investment Management’s Usana Health Sciences USNA Stock Holding History

Meadow Creek Investment Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$140K	Buy	+2,044	New	+$137K	﹤0.01%	1130

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meadow Creek Investment Management's USNA Position: Q3 2019 in Review

Meadow Creek Investment Management opened a new position in Usana Health Sciences (USNA) in Q3 2019: 2,044 shares worth $140K. The stake represents ﹤0.01% of the portfolio and ranks #1130 among its holdings.

169 funds tracked by Wall St. Rank hold USNA as of Q3 2019.

Meadow Creek Investment Management held 2,044 shares of Usana Health Sciences worth $140K as of Q3 2019.
Usana Health Sciences was a new Meadow Creek Investment Management position in Q3 2019.
Usana Health Sciences made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1130 holding.
169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.